With the aim to identify the upstream regulators of AREG and transforming growth factor-alpha (TGF-α) release, we focused our work on ADAM17, a metalloprotease, highly expressed in ovarian cancer and the major sheddase of these cell membrane hosted ligands [18, 35, 36]. Here, ADAM17 is linked to ovarian carcinoma.